ADELA

adela-logo

Adela develops innovative and accessible technologies focusing on the detection of cancer and other high-morbidity, high-mortality conditions through a routine blood test. Adelaโ€™s genome-wide methylome enrichment platform captures information efficiently from the entire methylome. Its technology distinguishes the most-highly informative (methylated) regions of the genome from non-informative regions and preferentially targets those regions for sequencing.

#SimilarOrganizations #People #Financial #Event #Website #More

ADELA

Social Links:

Industry:
Biotechnology Health Care Health Diagnostics Medical

Founded:
2020-01-01

Address:
Foster City, California, United States

Country:
United States

Website Url:
http://www.adelabio.com

Total Employee:
51+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
108 M USD

Technology used in webpage:
U.S. Server Location


Similar Organizations

base-molecular-resonance-technologies-logo

Base Molecular Resonance Technologies

Base Molecular Resonance Technologies detects every element on the periodic table and detects cancer.

intellihealth-logo

Intellihealth

Intellihealth is changing the perception of obesity and redefining how it is treated.

next-medical-logo

Next Medical

Next Medical is a developer and operator of a patient-centric telemedicine platform intended to fast-track medical testing.

prolocor-logo

Prolocor

Prolocor is a biotechnology company that develops diagnostic tests for cardiovascular diseases.

sapphiros-logo

Sapphiros

Sapphiros invest in and provide operational support to a select cohort of innovative diagnostics companies.

thrive-earlier-detection-logo

Thrive Earlier Detection

Thrive Earlier Detection is a healthcare company that integrates earlier cancer detection into routine medical care.

trice-medical-logo

Trice Medical

Trice Medical specializes in providing solutions for orthopedic diagnostics.

verismo-therapeutics-logo

Verismo Therapeutics

Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.


Current Advisors List

maneesh-jain_image

Maneesh Jain Board of Directors and Co-founder @ Adela
Board_member
2017-01-01

david-i-scheer_image

David I. Scheer Board Member @ Adela
Board_member

scott-bratman_image

Scott Bratman Board Member @ Adela
Board_member

Current Employees Featured

scott-bratman_image

Scott Bratman
Scott Bratman CEO @ Adela
CEO

daniel-carvalho_image

Daniel Carvalho
Daniel Carvalho CSO @ Adela
CSO

not_available_image

Chris Parker
Chris Parker Chief Business Officer @ Adela
Chief Business Officer
2022-03-01

karla-jarvis_image

Karla Jarvis
Karla Jarvis SVP, General Counsel & Secretary @ Adela
SVP, General Counsel & Secretary
2021-05-01

lisa-alderson_image

Lisa Alderson
Lisa Alderson Chief Executive Officer @ Adela
Chief Executive Officer
2023-12-01

Founder


daniel-carvalho_image

Daniel Carvalho

maneesh-jain_image

Maneesh Jain

scott-bratman_image

Scott Bratman

Investors List

f-prime-capital-partners_image

F-Prime Capital

F-Prime Capital investment in Series A - Adela

laboratory-corporation-of-america_image

LabCorp

LabCorp investment in Series A - Adela

orbimed-advisors_image

OrbiMed

OrbiMed investment in Series A - Adela

decheng-capital_image

Decheng Capital

Decheng Capital investment in Series A - Adela

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Series A - Adela

deerfield-management-4e45_image

Deerfield Management

Deerfield Management investment in Series A - Adela

deerfield_image

Deerfield

Deerfield investment in Series A - Adela

ra-capital-management_image

RA Capital Management

RA Capital Management investment in Series A - Adela

f-prime-capital-partners_image

F-Prime Capital

F-Prime Capital investment in Series A - Adela

orbimed-advisors_image

OrbiMed

OrbiMed investment in Series A - Adela

Key Employee Changes

Date New article
2023-12-14 Adela Appoints Precision Medicine Veteran Lisa Alderson as CEO

Official Site Inspections

http://www.adelabio.com Semrush global rank: 9.02 M Semrush visits lastest month: 445

  • Host name: aacb0a264e514dd48.awsglobalaccelerator.com
  • IP address: 99.83.190.102
  • Location: Seattle United States
  • Latitude: 47.54
  • Longitude: -122.3032
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98108

Loading ...

More informations about "Adela"

ADELA | A breakthrough approach to early detection - adelabio.com

Adela is developing best-in-class technology to accelerate the diagnosis and improve the management of cancer through blood tests. With a single, scalable platform, Adela can โ€ฆSee details»

Story Adela - uhncommercialization.ca

Adela advances precision medicine Developing next-generation cancer detection in a single blood draw Today, cancer and other diseases are often caught too late for treatments to be effective. โ€ฆSee details»

Adela 2025 Company Profile: Valuation, Funding

Information on valuation, funding, cap tables, investors, and executives for Adela. Use the PitchBook Platform to explore the full profile.See details»

Toronto biotech startup Adela raises $60-million from top U.S ...

Jun 23, 2021 A leading biotechnology startup from Toronto's University Health Network (UHN) has raised US$60-million form some of the biggest U.S. investors in the sector to help develop โ€ฆSee details»

Adela - Crunchbase Company Profile & Funding

Adela creates develops technologies centered around detecting high-risk conditions like cancer through routine blood tests.See details»

Adela Company Profile - Office Locations, Competitors, Revenue

Adela $60 m in total funding,. See insights on Adela including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»

Adela - VentureRadar

"Adela is focused on the detection of cancer and other high-morbidity, high-mortality conditions through a blood test. The DNA methylome is a rich source of information about human โ€ฆSee details»

Adela Appoints Precision Medicine Veteran Lisa Alderson as CEO

Serving most recently as interim CEO to Adela, she has already demonstrated her ability to engage and lead this mission-driven organization in delivering results.โ€See details»

Adela (USA) Funding: $108M

Jul 7, 2025 USA | Funding: $108M (+) Website: https://www.adelabio.com Adela creates develops technologies centered around detecting high-risk conditions like cancer through routine blood tests.See details»

Adela Announces Executive and Board of Directors Appointments โ€ฆ

May 23, 2022 "Her experience will be invaluable to Adela as we advance the organization towards commercialization." Lisa is the co-founder and CEO of Genome Medical, the leading โ€ฆSee details»

Adela - Portfolio Company Profile, Executives and Private Equity โ€ฆ

See Adela's complete profile, including its private equity owner and the number of its executive contacts in our database. Adela is a biotechnology company focused on the detection of โ€ฆSee details»

Biotech startup Adela procures $60m in Series A financing

Jun 23, 2021 Toronto-based biotechnology startup Adela has launched with a $60 million Series A financing. F-Prime led the round, with participation from OrbiMed, Deerfield Management, โ€ฆSee details»

Adela Announces Executive and Board of Directors Appointments โ€ฆ

May 23, 2022 Adela, Inc., focused on the detection of cancer and other high-morbidity, high-mortality conditions through a blood test, has made appointments to the Executive Team and โ€ฆSee details»

Adela Appoints Precision Medicine Veteran Lisa Alderson as CEO

Dec 15, 2023 FOSTER CITY - Adela, Inc., an innovator in blood testing for minimal residual disease monitoring and early cancer detection through a proprietary genome-wide methylome โ€ฆSee details»

ADELA | Adelaโ€™s Co-Founder & Chief Scientific Officer, Dr. Daniel โ€ฆ

The Canada Gairdner Awards celebrate the worldโ€™s best biomedical and global health researchers โ€ FOSTER CITY, Calif., April 11, 2025 /PRNewswire/ -- Adela is proud to announce that Daniel โ€ฆSee details»

adelabio.com - ADELA | Home

Adela is developing best-in-class technology to accelerate the diagnosis and improve the management of cancer through blood tests. With a single, scalable platform, Adela can โ€ฆSee details»

ADELA | News - adelabio.com

Adela is developing best-in-class technology to accelerate the diagnosis and improve the management of cancer through blood tests. With a single, scalable platform, Adela can โ€ฆSee details»

ADELA | Publications - adelabio.com

Adela is developing best-in-class technology to accelerate the diagnosis and improve the management of cancer through blood tests. With a single, scalable platform, Adela can โ€ฆSee details»

Adelaโ€™s multi-cancer blood test shows promise in detecting early โ€ฆ

Jun 16, 2023 Canadian newcomer Adela has shown that its test for detecting the faint traces of cancer in the bloodstream could spot 12 different types of the disease, including many in their โ€ฆSee details»

Adela Appoints Precision Medicine Veteran Lisa Alderson as CEO

Dec 15, 2023 Adela, Inc., an innovator in blood testing for minimal residual disease monitoring and early cancer detection through a proprietary genome-wide methylome enrichment โ€ฆSee details»

linkstock.net © 2022. All rights reserved